scispace - formally typeset
Journal ArticleDOI

Nanotechnology for Boosting Cancer Immunotherapy and Remodeling Tumor Microenvironment: The Horizons in Cancer Treatment.

Shan Gao, +4 more
- 02 Aug 2021 - 
- Vol. 15, Iss: 8, pp 12567-12603
TLDR
In this paper, the authors highlight the application, progress, and prospect of nanomedicine in the process of tumor immunoediting and also discuss several engineering methods to improve the efficiency of tumor treatment.
Abstract
Immunotherapy that harnesses the human immune system to fight cancer has received widespread attention and become a mainstream strategy for cancer treatment. Cancer immunotherapy not only eliminates primary tumors but also treats metastasis and recurrence, representing a major advantage over traditional cancer treatments. Recently with the development of nanotechnology, there exists much work applying nanomaterials to cancer immunotherapy on the basis of their excellent physiochemical properties, such as efficient tissue-specific delivery function, huge specific surface area, and controllable surface chemistry. Consequently, nanotechnology holds significant potential in improving the efficacy of cancer immunotherapy. Nanotechnology-based immunotherapy mainly manifests its inhibitory effect on tumors via two different approaches: one is to produce an effective anti-tumor immune response during tumorigenesis, and the other is to enhance tumor immune defense ability by modulating the immune suppression mechanism in the tumor microenvironment. With the success of tumor immunotherapy, understanding the interaction between the immune system and smart nanomedicine has provided vigorous vitality for the development of cancer treatment. This review highlights the application, progress, and prospect of nanomedicine in the process of tumor immunoediting and also discusses several engineering methods to improve the efficiency of tumor treatment.

read more

Citations
More filters
Journal ArticleDOI

Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes.

TL;DR: In this paper, the authors discuss the mechanism of immunotherapy from the perspective of dMMR/MSI, molecular pathways and TILs, and discuss how intratumor heterogeneity hinders the therapeutic effect.
Journal ArticleDOI

Recent advances in targeted delivery of paclitaxel nanomedicine for cancer therapy

TL;DR: A large number of patients with atypical prognosis and a weak immune response to chemotherapy are receiving treatment with these methods, suggesting a need to develop advanced therapeutic methods to effectively inhibit the proliferation of precancer and malignant tumors.
Journal ArticleDOI

Nanoparticle based medicines: approaches for evading and manipulating the mononuclear phagocyte system and potential for clinical translation.

TL;DR: How developing strategic methods of MPS 'pre-conditioning' with small molecule or biological drugs, as well as implementing strategic dosing regimens, such as 'decoy' nanoparticles, is essential to increasing nanoparticle therapeutic efficacy is discussed.
Journal ArticleDOI

Enhancement of antitumor immunotherapy using mitochondria-targeted cancer cell membrane-biomimetic MOF-mediated sonodynamic therapy and checkpoint blockade immunotherapy

TL;DR: In this paper , a cancer cell membrane-coated triphenylphosphonium (TPP) decorated nano-metal-organic framework (nMOF) was used to generate homologous, mitochondria-targeted platforms with a high rate of sonosensitizer loading.
Journal ArticleDOI

Protein-Delivering Nanocomplexes with Fenton Reaction-Triggered Cargo Release to Boost Cancer Immunotherapy.

TL;DR: The nanocomplexes with Fenton reaction-triggered protein release show great potentials to improve the immunotherapeutic efficacy of ICB via combination with CDT.
References
More filters
Journal ArticleDOI

Inflammation and cancer: back to Virchow?

TL;DR: A rationale for the use of cytokine and chemokine blockade, and further investigation of non-steroidal anti-inflammatory drugs, in the chemoprevention and treatment of malignant diseases is provided.
Journal ArticleDOI

Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion

TL;DR: A unifying conceptual framework called “cancer immunoediting,” which integrates the immune system’s dual host-protective and tumor-promoting roles is discussed.
Journal ArticleDOI

Cancer immunoediting: from immunosurveillance to tumor escape.

TL;DR: The historical and experimental basis of cancer immunoediting is summarized and its dual roles in promoting host protection against cancer and facilitating tumor escape from immune destruction are discussed.
Journal ArticleDOI

Oncology Meets Immunology: The Cancer-Immunity Cycle

TL;DR: Emerging clinical data suggest that cancer immunotherapy is likely to become a key part of the clinical management of cancer and may be more effective in combination with agents that target other steps of the cycle.
Related Papers (5)